1. Home
  2. STVN vs ESNT Comparison

STVN vs ESNT Comparison

Compare STVN & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • ESNT
  • Stock Information
  • Founded
  • STVN 1949
  • ESNT 2008
  • Country
  • STVN Italy
  • ESNT Bermuda
  • Employees
  • STVN N/A
  • ESNT N/A
  • Industry
  • STVN Containers/Packaging
  • ESNT Property-Casualty Insurers
  • Sector
  • STVN Consumer Discretionary
  • ESNT Finance
  • Exchange
  • STVN Nasdaq
  • ESNT Nasdaq
  • Market Cap
  • STVN 7.4B
  • ESNT 5.9B
  • IPO Year
  • STVN 2021
  • ESNT 2013
  • Fundamental
  • Price
  • STVN $22.87
  • ESNT $63.31
  • Analyst Decision
  • STVN Buy
  • ESNT Buy
  • Analyst Count
  • STVN 4
  • ESNT 5
  • Target Price
  • STVN $25.88
  • ESNT $66.80
  • AVG Volume (30 Days)
  • STVN 360.6K
  • ESNT 602.7K
  • Earning Date
  • STVN 11-06-2025
  • ESNT 11-07-2025
  • Dividend Yield
  • STVN 0.27%
  • ESNT 1.97%
  • EPS Growth
  • STVN 19.61
  • ESNT N/A
  • EPS
  • STVN 0.60
  • ESNT 6.87
  • Revenue
  • STVN $1,373,219,524.00
  • ESNT $1,263,558,000.00
  • Revenue This Year
  • STVN $8.33
  • ESNT $4.19
  • Revenue Next Year
  • STVN $10.12
  • ESNT $1.54
  • P/E Ratio
  • STVN $38.31
  • ESNT $9.16
  • Revenue Growth
  • STVN 6.97
  • ESNT 2.04
  • 52 Week Low
  • STVN $17.81
  • ESNT $51.61
  • 52 Week High
  • STVN $28.00
  • ESNT $65.90
  • Technical
  • Relative Strength Index (RSI)
  • STVN 45.20
  • ESNT 62.30
  • Support Level
  • STVN $20.67
  • ESNT $60.08
  • Resistance Level
  • STVN $24.01
  • ESNT $63.77
  • Average True Range (ATR)
  • STVN 1.23
  • ESNT 1.30
  • MACD
  • STVN 0.06
  • ESNT 0.25
  • Stochastic Oscillator
  • STVN 45.08
  • ESNT 92.57

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About ESNT Essent Group Ltd.

Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.

Share on Social Networks: